THIRD EXTENSION - GRANTED
granted
on 28 Aug 2024
Last Applicant/ Owned by
801 Capitola Drive, Suite 12
Durham
NC
27713
Serial Number
97244151 filed on 28th Jan 2022
Registration Number
N/A
Correspondent Address
B. Brett Heavner
B. Brett Heavner FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER LLP
WASHINGTON, DC 20001
United States
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
XILIS
Pharmaceutical drug development and testing of anti-cancer drugs Medical devices in the nature of an adjustable microscale encapsulation apparatus used to manipulate and study complex patient-derived cell tissue by measuring cell viability and drug response to aid in the development of personalized patient therapy and treatment of tumors Medical testing for diagnostic purposes and medical treatm Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Medical testing for diagnostic purposes and medical treatment services in the field of oncology
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical drug development and testing of anti-cancer drugs
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [010]
Medical Instrument Products
Medical devices in the nature of an adjustable microscale encapsulation apparatus used to manipulate and study complex patient-derived cell tissue by measuring cell viability and drug response to aid in the development of personalized patient therapy and treatment of tumors
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97244151
Mark Type
No Service Mark
Attorney Docket Number
No 15844.0006
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 05th Sep 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 05th Sep 2024 | REVIEW OF CORRESPONDENCE COMPLETE |
| 28th Aug 2024 | SOU EXTENSION 3 GRANTED |
| 28th Aug 2024 | SOU EXTENSION 3 FILED |
| 28th Aug 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 28th Aug 2024 | SOU TEAS EXTENSION RECEIVED |
| 22nd Aug 2024 | CORRECTED NOA E-MAILED |
| 22nd Aug 2024 | DIVISIONAL PROCESSING COMPLETE |
| 14th Aug 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 21st Jun 2024 | TEAS REQUEST TO DIVIDE RECEIVED |